Free Newsletter
Software release promotes scaffolding
Drug absorption and pharmacokinetics simulation company Simulations Plus (NASDAQ: SLP) has released version 4.7 of its ClassPharmer software for the analysis of chemical libraries and design of molecular structures. The update is said to enhance data mining and molecule design capabilities.
The software now equips users to replace parts of a candidate molecule with another structure, or scaffold. The scaffold-hopping technique allows chemists to salvage drug candidates that otherwise would have been shelved due to synthetic challenges, intellectual property restrictions, or liabilities in absorption, distribution, metabolism, excretion and toxicity (ADMET). In silico scaffold hopping lets researchers screen hundreds of thousands of replacement scaffolds without synthesizing and testing them.
ClassPharmer may be coupled with the company's ADMET Predictor software.
- here's the announcement
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: